Biotech company Anixa Biosciences has received a Notice of Allowance for a key patent application covering its ovarian cancer vaccine technology from the United States Patent...
AbbVie has announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE (mirvetuximab soravtansine-gynx) in women with folate...
Researchers have identified a novel trigger of a deadly form of ovarian cancer: a subset of progenitor cells that reside in fallopian tube supportive tissue, or...
In a new study, IgE antibodies have been shown to help activate monocytes – a type of immune cell – making them more effective at attacking...
AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images, an international study has shown. Researchers have developed and validated neural network models...
A new study has revealed the global prevalence of ovarian cancer along with the changing trends in rates. For the study, researchers analysed patterns and trends...
An MRI-based imaging technique can predict the response of ovarian cancer tumours to treatment and rapidly reveals how well treatment is working in patient-derived cell models....
A new approach to treating ovarian cancer has been discovered that, in preclinical laboratory testing, shrinks tumours and improves survival rates while simultaneously making tumours more...
Researchers have discovered a way that ovarian cancer tumours manipulate their environment to resist immunotherapy and identified a drug target that could overcome that resistance. The...
A combination of two drugs that can block the growth of cancer cells has shown promising results in women with a form of ovarian cancer that...
